Sanara MedTech rises after H.C. Wainwright initiates coverage with 'buy' rating
23/12/2024 18:41
** Shares of medical technology company Sanara MedTech
SMTI.O rise about 2.7% to $34.6
** H.C. Wainwright initiates coverage of SMTI with "buy"
rating
** Brokerage says SMTI's successful market penetration and
geographic expansion could continue to drive topline growth in
the coming quarters
** Company's products and services improve clinical outcomes
in the surgical and chronic wound care markets, which also
reduce healthcare expenditure - brokerage
** "Commercialized surgical wound care products have been
driving revenue growth since 2019" - H.C. Wainwright
** Brokerage sets PT at $50, about 48.4% upside on stock's
last close
** Including session's moves, stock down ~16.1% YTD
(Reporting by Prakhar Srivastava in Bengaluru)
((Prakhar.srivastava2@thomsonreuters.com))